BTAI
BioXcel Therapeutics Inc.
$2.78
-$0.21(-7.02%)
50
Overall
--
Value
50
Tech
--
Quality
Market Cap
$43.52M
Volume
1.49M
52W Range
$1.17 - $13.28
Target Price
$8.25
EPS Estimates Overview
| Current Quarter | $-1.54 | Next Quarter | $-0.82 |
| Current Year | $-6.93 | Next Year | $-4.8 |
| QoQ Growth | +46.8% | YoY Growth | +30.7% |
| 3Y EPS CAGR | +28.7% | Target Price | $8.25 |
| Consensus | Buy | Upside | +196.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BTAI | $2.78 | -7.0% | 1.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioXcel Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW